Octreotide promotes weight loss via suppression of intestinal MTP and apoB48 expression in diet-induced obesity rats

Nutrition

Volumn 29, Issue 10, 2013, Pages 1259-1265

  Huang, Wei ^a   Liu, Rui ^a   Ou, Yan ^a   Li, Xian ^a   Qiang, Ou ^a   Yu, Tao ^a   Tang, Cheng Wei ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Alimentary obesity; ApolipoproteinAIV; ApolipoproteinB48; Microsomal triglyceride transfer protein; Octreotide

Indexed keywords

APOLIPOPROTEIN A4; APOLIPOPROTEIN B48; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MESSENGER RNA; MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN; OCTREOTIDE; TRIACYLGLYCEROL;

ABDOMINAL FAT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY FAT; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET RESTRICTION; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEEDING; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; INSULIN BLOOD LEVEL; INTESTINE; LIPID ABSORPTION; LIPID BLOOD LEVEL; LIPID DIET; MALE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION; WESTERN BLOTTING;

RATTUS;

ALIMENTARY OBESITY; APOLIPOPROTEINAIV; APOLIPOPROTEINB48; MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN; OCTREOTIDE;

ANIMALS; APOLIPOPROTEIN B-48; APOLIPOPROTEINS A; BLOOD GLUCOSE; CARRIER PROTEINS; CHOLESTEROL; DIET, HIGH-FAT; DOWN-REGULATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FASTING; INSULIN; INTESTINAL ABSORPTION; INTESTINES; MALE; OBESITY; OCTREOTIDE; RATS; RATS, SPRAGUE-DAWLEY; TRIGLYCERIDES; WEIGHT LOSS;

EID: 84884211141     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2013.01.013     Document Type: Article

References (44)

1. Nguyen D.M., Hashem B.E. The epidemiology of obesity. Gastroenterol Clin North Am 2010, 39:1-7.
2. Bray G.A., Paeratakul S., Popkin B.M. Dietary fat and obesity: a review of animal, clinical and epidemiological studies. Physiol Behav 2004, 83:549-555.
3. Hussain M.M., Kancha R.K., Zhou Z., Luchoomun J., Zu H., Bakillah A. Chylomicron assembly and catabolism: role of apolipoproteins and receptors. Biochim Biophys Acta 1996, 1300:151-170.
4. Hernández Vallejo S.J., Alqub M., Luquet S., Cruciani-Guglielmacci C., Delerive P., Lobaccaro J.M., et al. Short-term adaptation of postprandial lipoprotein secretion and intestinal gene expression to a high-fat diet. Am J Physiol Gastrointest Liver Physiol 2009, 296:G782-G792.
5. Lu S., Yao Y., Meng S., Black D.D. Overexpression of apolipoprotein A-IV enhances lipid transport in newborn swine intestinal epithelial cells. J Biol Chem 2002, 277:31929-31937.
6. Kendrick J.S., Chan L., Higgins J.A. Superior role of apolipoprotein B48 over apolipoprotein B100 in chylomicron assembly and fat absorption: an investigation of apobec-1 knock-out and wild-type mice. Biochem J 2001, 356:821-827.
7. Phillips C., Owens D., Collins P., Tomkin G.H. Microsomal triglyceride transfer protein: does insulin resistance play a role in the regulation of chylomicron assembly?. Atherosclerosis 2002, 160:355-360.
8. Tang C.W. Research progress of gastrointestinal peptides. Gastroenterology and hepatology: theoretic basis and clinical advances 2004, 76-86. Guangdong world Publishing Corporation, Guangzhou. S.D. Xiao (Ed.).
9. Van Op den bosch J., Adriaensen D., Van Nassauw L., Timmermans J.P. The role(s) of somatostatin, structurally related peptides and somatostatin receptors in the gastrointestinal tract: a review. Regul Pept 2009, 156:1-8.
10. Lustig R.H., HindS P.S., Smith K.R., Ringwald-Smith K., Kaste S.C., Schreiber R.E., et al. Octreotide therapy of pediatric hypothalamic obesity: a double-blind, placebo-controlled trial. J Clin Endocrinol Metab 2003, 88:2586-2592.
11. Lustig R.H., Greenway F., Mieyer P.V., Christensen R.K., Kaste S.C., Schreiber R.E., et al. A multicenter, randomized, double-blind, placebo-controlled, dose-finding trial of a long-acting formulation of octreotide in promoting weight loss in obese adults with insulin hypersecretion. Int J Obes (Lond) 2006, 30:331-341.
12. Wei N., Liu R., Ou Y., Li X., Qiang O., Guo W., et al. Effects of octreotide on glucose transporter type 2 expression in obese rat small intestine. World J Gastroenterol 2011, 17:4434-4439.
13. Fiebrich H.B., Van Den Berg G., Kema I.P., Links T.P., Kleibeuker J.H., Van Beek A.P., et al. Deficiencies in fat-soluble vitamins in long-term users of somatostatin analogue. Aliment Pharmacol Ther 2010, 32:1398-1404.
14. Wang C., Yang N., Xu M., Yuan X., Liu L., Sun X. Different susceptibility to high-fat diet induced obesity in rats. Acta Med Univ Sci Technol Huazhong 2005, 34:65-68.
15. Liu R., Sun C.H., Wang S.R., Yu X.F., Fu R.X. Study on obesity related index between DIO- R and DIO of rats. Chin J Public Health 2003, 5:563-565.
16. Wang Z.X., Chen J.W., Zhou Y.K. An experimental study of the effects of octreotide on small intestinal mucosa in rats. J Math Med 2002, 15:125-127.
17. Van De Kamer J.H., Ten Bokkel Huinink H., Weyers H.A. Rapid method for the determination of fat in feces. J Biol Chem 1949, 177:347-355.
18. Jiang X.H., Li N., Zhu W.M., Li J.S. Effect of enteral supplement of arginine on intestinal adaptation and its mechanism in experimental rats with short bowel syndrome. Zhonghua Wei Chang Wai Ke Za Zhi 2009, 12:522-525.
19. Assmann G., Schriewer H., Schmitz G., Hägele E.O. Quantification of high-density-lipoprotein cholesterol by precipitation with phosphotungstic acid/MgCl2.Clin Chem 1983, 29:2026-2030.
20. Ding S.L., Chi M.M., Scull B.P., Rigby R., Schwerbrock N.M.J., Magness S., et al. High-fat diet: Bacteria interactions promote intestinal inflammation which precedes and correlates with obesity and insulin resistance in mouse. PLoS One 2010, 5:e12191.
21. Améen C., Edvardsson U., Ljungberg A., Rigby R., Schwerbrock N.M., Magness S., et al. Activation of peroxisome proliferator-activated receptor increases the expression and activity of microsomal triglyceride transfer protein in the liver. J Biol Chem 2005, 280:1224-1229.
22. Spiegelman B.M., Flier J.S. Obesity and the regulation of energy balance. Cell 2001, 104:531-543.
23. Stan S., Delvin E., Lambert M., Levy E. ApoA-IV: an update on regulation and physiologic functions. Biochim Biophys Acta 2003, 1631:177-187.
24. Carrière V., Vidal R., Lazou K., Lacasa M., Delers F., Ribeiro A., et al. HNF-4-dependent induction of apolipoprotein A-IV gene transcription by an apical supply of lipid micelles in intestinal cells. J Biol Chem 2005, 280:5406-5413.
25. Lu S., Yao Y., Cheng X., Mitchell S., Leng S., Meng S., et al. Overexpression of apolipoproteinAIV enhanced lipid serection in IPEC-1 cells by increasing chylomicron size. J Biol Chem 2006, 281:3473-3483.
26. Tennyson G.E., Sabatos C.A., Higuchi K., Meglin N., Brewer H.B. Expression of apolipoproteinB mRNAs encoding higher- and lower-molecular weight isoproteins in rat liver and intestine. Proc Natl Acad Sci USA 1989, 86:500-504.
27. Nzekwu M.M.U., Ball G.D.C., Jetha M.M., Beaulieu C., Proctor S.D. Apolipoprotein B48: a novel marker of metabolic risk in overweight children. Biochem Soc T 2007, 35:484-486.
28. Wang A.B., Liu D.P., Liang C.C. Regulation of human apolipoproteinB gene expression at multiple levels. Exp Cell Res 2003, 290:1-12.
29. Hussain M.M., Shi J., Dreizen P. Microsomal triglyceride transfer protein and its role in apoB-lipoprotein assembly. J Lipid Res 2003, 44:22-32.
30. Qin B.L., Qiu W., Avramoglu R.K., Adeli K. Tumor necrosis factor-α induces intestinal insulin resistance and stimulates the overproduction of intestinal apolipoprotein B48-containing lipoproteins. Diabetes 2007, 56:450-461.
31. Guo W., Liu R., Qiang O., Li X., Tang C.W. Study of serum TNF-α, GTH and MDA levels in obesity-prone and obesity-resistant rats induced by high fat diet. Mod Prev Med 2009, 36:2434-2437.
32. Hussain M.M., Nijstad N., Franceschini L. Regulation of microsomal triglyceride transfer protein. Clin Lipidol 2011, 6:293-303.
33. Phillips C., Bennett A., Anderton K., Owens D., Collins P., White D., et al. Intestinal rather than hepatic microsomal triglyceride transfer protein as a cause of postprandial dyslipidemia in diabetes. Metabolism 2002, 51:847-852.
34. Lewis G.F., Uffelman K., Naples M., Szeto L., Haidari M., Adeli K. Intestinal lipoprotein overproduction, a newly recognized component of insulin resistance, is ameliorated by the insulin sensitizer rosiglitazone: studies in the fructose-fed Syrian golden hamster. Endocrinology 2005, 146:247-255.
35. Zhao H., Lu Z., Bie X., Lü F. Analysis of positional distribution of fatty acids in triacylglycerols from lard by high performanceliquid chromatography. Chinese J Chromatography 2005, 23:142-145.
36. Privett O.S., Blank M.L., Verdino B. Influence of dietary fat on triglycerid structure in the Rat. J Nutr 1965, 85:187-195.
37. Honunelberg P.P., Plat J., Langen R.C., Sehols A.M., Mensink R.P. Fatty acid induced NF-kappaB activation and insulin resistance in skeletal muscle are chain length dependent. Am J Physiol Endocrinol Metab 2009, 296:E114-E120.
38. Storlien L.H., Jenkins A.B., Chisholm D.J., Pascoe W.S., Khouri S., Kraegen E.W. Influence of dietary fat composition on development of insulin resistance in rats: Relationship to muscle triglyceride and omega-3 fatty acids in muscle phospholipids. Diabetes 1991, 40:280-289.
39. Mlinar B., Marc J., Janez A., Pfeifer M. Molecular mechanisms of insulin resistance and associated diseases. Clin Chim Acta 2007, 375:20-35.
40. Tirone T.A., Norman M.A., Moldovan S., DeMayo F.J., Wang X.P., Brunicardi F.C. Pancreatic somatostatin inhibits insulin secretion via SSTR-5 in the isolatedperfused mouse pancreas model. Pancreas 2003, 26:e67-e73.
41. Chowers Y., Cahalon L., Lahav M., Schor H., Tal R., Bar-Meir S., et al. Somatostatin through its specific receptor inhibits spontaneous and TNF-α- and bacteria-induced IL-8 and IL-1β secretion from intestinal epithelial cells. J Immunol 2000, 165:2955-2961.
42. Stange E.F., Schneider A., Schusdziarra V., Ditschuneit H. Inhibitory effects of somatostatin on growth and differentiation in cultured intestinal mucosa. Horm Metab Res 1984, 16:74-78.
43. Thompson J.S. Somatostatin analogue predisposes enterocytes to apoptosis. J Gastrointest Surg 1998, 2:167-173.
44. Patterson A.P., Chen Z., Rubin D.C., Moucadel V., Iovanna J.L., Brewer H.B., et al. Developmental regulation of ApolipoproteinB mRNA editing is an autonomous function of small intestine involving homeobox gene Cdx1. J Biol Chem 2003, 273:7600-7606.